• Published in Advances in Therapy (2025)

  • Collaborator: Takeda

  • Authors: Marjorie Argollo, Yoon K. An, Nahla Azzam, Domingo C. Balderramo, Olga Fadeeva, Chia-
    Jung Kuo, Julie Laurent, Elenore Uy

Understanding patient preferences is important for facilitating informed decision-making in managing patients with inflammatory bowel disease (IBD). This study explored the preferences of patients with Crohn’s disease (CD) and ulcerative colitis (UC) regarding advanced therapy treatment attributes in five non-Western countries: Argentina, Australia, Brazil, Saudi Arabia and Taiwan.